Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
NewGenIvf Group Limited (NIVF)
USD1.37
-0.06 (-4.20%)
TH NASDAQ Healthcare Medical - Care Facilities
Address
PS Tower 10110
Bangkok, TH
Bangkok, TH
CEO
Wing Fung Siu
Website
newgenivf.com
IPO
2022-03-18
CIK 1981662 ISIN VGG0544E1473
Also trades on
NASDAQ Capital Market · NIVFW (USD)
NASDAQ Global Market · NIVF (USD)
Description
Operating out of its headquarters in Bangkok, Thailand, NewGenIvf Group Limited specializes in delivering assisted reproductive services. The firm is committed to fulfilling the desire for family through a variety of fertility treatments. Its extensive service portfolio includes conventional in-vitro fertilization (IVF), egg donation, and surrogacy, all complemented by comprehensive ancillary care.
News Sentiment (7d)
Based on only 1 article — low confidence
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD1.37
-0.06 (-4.20%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
6M
Beta
-0.04
Float Shares
568.5K
Free Float %
100.0%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -11.65% | +0.00% | -47.09% | -72.59% | -95.74% | -89.01% | -99.12% | -100.00% | -100.00% | -100.00% | -100.00% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
1.37
Ratings Trend (MoM)
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
1.75
Distress
Piotroski F-Score
5 / 9
Average
MOAT Score
1 / 10
No MOAT
Composite Rating
A+
Overall Score
4 / 5
High
DCF Score
4 / 5
High
ROE Score
5 / 5
High
ROA Score
5 / 5
High
D/E Score
2 / 5
Medium
P/E Score
3 / 5
Medium
P/Book Score
5 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Care Facilities: +10.2%-13.0% Q4'25: -6.2% (vs Q4'23)
-
EPS growth Medical - Care Facilities: +19.2%+175.3% ★ Q4'25: -140.8% (vs Q4'23)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+172.0% Q4'25: -446.2% (vs Q4'23)
-
EBIT margin Medical - Care Facilities: +11.3%+218.9% ★ Q4'25: -510.6% (vs Q4'23)
-
ROIC Medical - Care Facilities: +6.8%+34.4% ★ Q4'25: -96.7% (vs Q4'23)
-
Share dilution Medical - Care Facilities: +0.0%+0.0% Q4'25: +124.4% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×0.45× ★ Q4'25: -0.17× (vs Q4'23)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|
| Revenue |
4.73M
est: 4.89M (-3.4%)
|
65.10M
65.10M – 65.10M
+1,230.9% YoY
|
180.40M
180.40M – 180.40M
+177.1% YoY
|
270.60M
270.60M – 270.60M
+50.0% YoY
|
| EBITDA |
10.84M
est: 1.31M (+724.8%)
|
17.50M
17.50M – 17.50M
+1,230.9% YoY
|
48.49M
48.49M – 48.49M
+177.1% YoY
|
72.73M
72.73M – 72.73M
+50.0% YoY
|
| EBIT |
10.35M
est: 1.10M (+838.3%)
|
14.67M
14.67M – 14.67M
+1,230.9% YoY
|
40.66M
40.66M – 40.66M
+177.1% YoY
|
60.99M
60.99M – 60.99M
+50.0% YoY
|
| Net Income |
9.88M
est: 216.00M (-95.4%)
|
2.79M
2.79M – 2.79M
-98.7% YoY
|
5.49M
5.49M – 5.49M
+97.0% YoY
|
8.65M
8.65M – 8.65M
+57.4% YoY
|
| SGA |
11.68M
est: 3.65M (+219.9%)
|
48.60M
48.60M – 48.60M
+1,230.9% YoY
|
134.69M
134.69M – 134.69M
+177.1% YoY
|
202.03M
202.03M – 202.03M
+50.0% YoY
|
| EPS |
16.80
est: 367.20 (-95.4%)
|
4.74
4.74 – 4.74
-98.7% YoY
|
9.34
9.34 – 9.34
+97.0% YoY
|
14.70
14.70 – 14.70
+57.4% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-28 | A+ | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-27 | A+ | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-26 | A+ | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-22 | A+ | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-21 | A+ | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-20 | A+ | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-19 | A+ | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-18 | A+ | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-15 | A+ | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-14 | A+ | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-13 | A+ | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-12 | A+ | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-11 | A+ | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 5/5 |
| 2026-05-08 | A+ | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-07 | A+ | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-06 | A+ | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-05 | A+ | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-04 | A+ | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 4/5 | 5/5 |
| 2026-05-01 | A+ | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-30 | A+ | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-29 | A+ | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-28 | A+ | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-27 | A+ | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-24 | A+ | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-23 | A+ | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-22 | A+ | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-21 | A+ | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-20 | A+ | 4/5 | 3/5 | 5/5 | 5/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-17 | A | 4/5 | 3/5 | 5/5 | 5/5 | 1/5 | 3/5 | 5/5 |
| 2026-04-16 | A | 4/5 | 3/5 | 5/5 | 5/5 | 1/5 | 3/5 | 5/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-6.76M
OE per share TTM
-12.30
Owner's Yield
-1,262.90%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
9.3%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
4
Total invested
3.9K
Insider transactions (90d)
5
Beneficial owners (>5%)
12
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Wai Lam Tina Fong | 4.11M | 40.50% | — | 4.11M | — | 10.00 | IN | Kong, China | 2024-04-10 | ↗ |
| 2 | Wing Fung Alfred Siu | 4.11M | 40.50% | — | 4.11M | — | 10.00 | IN | Kong, China | 2024-04-10 | ↗ |
| 3 | Capital Markets LLC | 1.57M | 15.50% | 1.57M | — | 1.57M | — | BD | York | 2024-11-13 | ↗ |
| 4 | Grossman | 1.57M | 15.50% | 1.57M | — | 1.57M | — | IN | States of America | 2024-11-13 | ↗ |
| 5 | Urbach | 1.57M | 15.50% | 1.57M | — | 1.57M | — | IN | States of America | 2024-11-13 | ↗ |
| 6 | Opportunities Master Fund II, L.P. | 1.13M | 9.90% | — | 1.13M | — | 1.13M | PN | Delaware | 2024-10-10 | ↗ |
| 7 | Opportunities VI LLC | 1.13M | 9.90% | — | 1.13M | — | 1.13M | OO | Delaware | 2024-10-10 | ↗ |
| 8 | Partners Opportunities Management, LLC | 1.13M | 9.90% | — | 1.13M | — | 1.13M | IA, OO | Delaware | 2024-10-10 | ↗ |
| 9 | Propper | 1.13M | 9.90% | — | 1.13M | — | 1.13M | HC | Delaware | 2024-10-10 | ↗ |
| 10 | Ruiz-Gimenez | 1.13M | 9.90% | — | 1.13M | — | 1.13M | HC | Delaware | 2024-10-10 | ↗ |
| 11 | White Lion Capital, LLC | 1.05M | 9.99% | 1.05M | — | 1.05M | — | OO | Nevada | 2024-12-05 | ↗ |
| 12 | Kit Yee Sze | 546.9K | 5.40% | 546.9K | — | 546.9K | — | IN | Hong Kong, China | 2024-04-10 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
4
+4 vs prev Q
New positions
4
Closed positions
0
Increased
4
Reduced
0
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | TOWER RESEARCH CAPITAL LLC (TRC) | 1.5K +1.5K (+100.0%) | 3.4K +3.4K (+100.0%) | 0.26% +0.255 pp | 0.00% +0.000 pp | USD2.26 +0.0% | 1 qtrs NEW |
| 2 | UBS GROUP AG | 200.00 +200.0 (+100.0%) | 452.00 +452.0 (+100.0%) | 0.03% +0.034 pp | 0.00% +0.000 pp | USD2.26 +0.0% | 1 qtrs NEW |
| 3 | SBI SECURITIES CO., LTD. | 5.00 +5.0 (+100.0%) | 11.00 +11.0 (+100.0%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD2.20 +2.7% | 1 qtrs NEW |
| 4 | MORGAN STANLEY | 1.00 +1.0 (+100.0%) | 2.00 +2.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.00 +13.0% | 1 qtrs NEW |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
4.00
Bullish
Ratio by volume
3.00
Bullish
Buys
4
Sells
1
Shares acquired
279.2K
Shares disposed
85.3K
Cash buys
2.00
Cash sales
1.00
Net activity
+193,919
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-27 | HRT FINANCIAL LP | 10% Owner | S-Sale | D | Common Stock | 85,317 | 0.80 | 68.3K | 54,561 | D | ↗ |
| 2026-05-26 | HRT FINANCIAL LP | 10% Owner | P-Purchase | A | Common Stock | 27,993 | 0.92 | 25.8K | 139,878 | D | ↗ |
| 2026-05-22 | HRT FINANCIAL LP | 10% Owner | — | — | Common Stock | 0 | 0.00 | — | 111,885 | D | ↗ |
| 2026-05-04 | Siu Wing Fung Alfred | Director / Officer | A-Award | A | Stock Options (Right to Buy) | 56,851 | 0.00 | 5.69 | 56,881 | D | ↗ |
| 2026-05-04 | Fong Hei Yue Tina | Director / Officer | A-Award | A | Stock Options (Right to Buy) | 56,851 | 0.00 | 5.69 | 56,890 | D | ↗ |
| 2026-03-18 | Tam Chun Wa | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2026-03-18 | Siu Wing Fung Alfred | Director / Officer | — | — | Class B Ordinary Shares | 0 | 0.00 | — | 30 | D | ↗ |
| 2026-03-18 | Fong Hei Yue Tina | Director / Officer | — | — | Class B Ordinary Shares | 0 | 0.00 | — | 39 | D | ↗ |
| 2026-03-18 | Ching Chan Florianna Ann Chi Wan | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2026-03-18 | Chan Chung Ho | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2026-03-18 | Au Hok Man Jefferson | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-04-03 | CHARDAN CAPITAL MARKETS LLC | 10% Owner | — | — | Class A Ordinary Shares | 0 | 0.00 | — | 1,569,000 | D | ↗ |
Executive team
Top executives
EBIT / Employee
1.4K
Shares Outstanding
568.4K
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Hei Yue Fong | Co-Founder, Chief Marketing Officer & Director | 1M | female |
| Wing Fung Siu | Co-Founder, Chairman & Chief Executive Officer | 718.1K | male |
| Fai Chung | Chief Financial Officer | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for NIVF
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
